CRC has an immunosuppressive TME which prevents the development of a good reaction to ICB therapies. There may be So an urgent must determine the strategies reprogram this suppressive TME so that you can improve immunotherapy efficacy. In the current research, we made use of CRISPR KO screens to find https://manueluacwr.verybigblog.com/28175182/5-simple-statements-about-as1842856-explained